Rectal cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) A case with primary rectal cancer is scheduled for TME and LLND 2) A case with histologically confirmed adenocarcinoma 3) Informed consent is obtained for participation in the study 4) Regarding Step 1, the postoperative registration is permissible.
Exclusion criteria
Exclusion criteria: 1) A case with a contraindication for MRI, such as use of artificial devices (e.g., cardiac pacemaker) 2) A case wherein assessing the status of LLN metastasis on MRI imaging is difficult because of intrapelvic artifacts 3) A case with an intrapelvic neoplasm, barring colorectal cancer, such as prostate cancer, bladder cancer, uterine cancer, and ovarian cancer. 4) A patient who is deemed to be inappropriate for study enrolment by the principal investigator or researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The diagnostic sensitivity of LLN metastasis on MRI | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of the diagnosis of LLN metastasis on MRI. 2. The coincidence ratio of morphologic change assessments among the observers 3. The correlation between extramural venous invasion (EMVI) of the primary lesion and LLN metastasis 4. The influence of neoadjuvant therapy for the diagnosis of LLN metastasis on MRI 5. The correlation between the LLN metastasis diagnosed by MRI and the patients' prognosis 6. The difference between the diagnostic accuracy of LLN metastasis on MRI and CT | — |
Countries
Japan,Europe
Contacts
The University of Tokyo Department of Surgical Oncology